ABL Bio Rebounds to 87,300 Won After Two-Day Correction... Biotech Included in Government's Future Technology 'Seeds'
ABL Bio snapped a two-day losing streak and rebounded during the morning session on the 13th, recovering its share price. As of the morning of the 13th, ABL Bio is trading at 87,300 won, up 500 won (0.58%) from the previous trading day. While the gain is modest, the fact that it represents a reboun

ABL Bio snapped a two-day losing streak and rebounded during the morning session on the 13th, recovering its share price.
As of the morning of the 13th, ABL Bio is trading at 87,300 won, up 500 won (0.58%) from the previous trading day. While the gain is modest, the fact that it represents a rebound following two consecutive declining sessions signals a subtle shift in the stock's trajectory. In the stock market, rebounds after consecutive declines are driven by a variety of factors, including an influx of buying interest following short-term drops and changes in supply and demand dynamics.
In particular, biotech stocks tend to exhibit high short-term volatility due to their sensitivity to individual catalysts such as research and development (R&D) achievements, clinical trial progress, and technology transfer agreements. For ABL Bio, which develops new drugs based on bispecific antibody technology, the development progress of drug candidates, global partnerships, and technology transfer outcomes are cited as key factors in assessing the company's business value.
There are also positive expectations at the industry level. The inclusion of the biotech sector in the government's recently announced plan to foster future growth technologies is adding weight to long-term R&D strategies. The government judged that in the midst of rapidly shifting global technological competition, merely maintaining the competitiveness of existing key industries would not be sufficient to guarantee sustainable growth. Accordingly, it laid out a direction to select and cultivate the "seeds" of future technologies over the long term in order to prepare for next-generation industries that will drive the national economy in 10 to 20 years.
The biotech industry is a representative long-term investment sector, requiring significant time from initial research to actual commercialization. Despite the uncertainty of outcomes in the early research phase, securing core technologies can lead to expansion into new drugs, platform technologies, and global technology exports, classifying it as a future growth engine. As it takes considerable time for a single candidate to pass through clinical trials and approval processes to enter the market, the long-term investment environment and the creation of a technology ecosystem are critical variables that determine industry competitiveness.
However, no direct causal relationship has been confirmed between the government's biotech promotion policy and ABL Bio's share price rebound on this day. The day's stock price movement should be viewed as the result of a complex interplay of factors, including supply and demand changes following the recent correction, the overall sentiment in the biotech sector, and the company's individual business variables.
Having weathered a two-day correction and turned back upward to reclaim the 87,000-won range, ABL Bio is expected to see the progress of its new drug pipeline and its global business performance serve as the key variables shaping its future stock price trajectory.
[This article was written with the assistance of AI. This article is provided as reference material for investment decisions and does not recommend the purchase or sale of any specific stock. Securities reports reflect analysis and forecasts as of the time of writing, and actual results and stock price movements may differ.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.


![[Breaking] Boratial Consortium Selected as Preferred Bidder for Acquisition of Haitai HTB Stake](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581419%2F479dac739b049517%2Fvariants%2Fhero.webp&w=1920&q=75)
